Latest updates in treatment for the field of HER2-positive breast cancer
Latest updates in treatment for the field of HER2-positive breast cancer
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer
Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes
War in Ukraine: Global cancer aid to support refugees
ASCO and WHO to collaborate on quality indicators for cancer facilities
Spotlight on global cancer control at ASCO 2022
UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries
Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy
Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy
Comment: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy
Luminal A-type breast cancer patients with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy
Biomarker analysis of the NeoALTTO trial provides oncofertility insight for younger breast cancer patients